Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (NCAP)
Description
| Amount: | 5 μg / peptide as individual peptide and in matrix pools |
|---|---|
| Application: | T-cell immunity |
| Category: | Epitope Mapping Peptide Sets, PepMix Peptide Pools |
| Condition / Topic: | Covid-19, Infection, Respiratory infection |
| Layout: | Freeze-dried in 1 x 96 tube rack, Freeze-dried in 3 x 96 tube racks |
| Organism: | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
| Protein Name: | Nucleoprotein |
| Purity: | Research Plus Grade: each peptide is guaranteed to be main product (HPLC/MS), crude (major peak by LC-MS is guaranteed to be peptide of interest for each peptide) |
| Quantification: | No |
|
Sequence: |
MSDNGPQNQRNAPRITFGGPSDSTGSNQNGERSGARSKQRRPQGLPNNTASWFTALTQHGKEDLKFPRGQGVPINTNSSPDDQIGYYRRATRRIRGGDGKMKDLSPRWYFYYLGTGPEAGLPYGANKDGIIWVATEGALNTPKDHIGTRNPANNAAIVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSPARMAGNGGDAALALLLLDRLNQLESKMSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKAYNVTQAFGRRGPEQTQGNFGDQELIRQGTDYKHWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYTGAIKLDDKDPNFKDQVILLNKHIDAYKTFPPTEPKKDKKKKADETQALPQRQKKQQTVTLLPAADLDDFSKQLQQSMSSADSTQA
|
|---|---|
|
Specifications: |
Peptide scan (optimized scan into 15 mers) |
